Clinical Studies and Research

Our hepatologists are actively engaged in clinical research into novel therapies, improved diagnostic modalities, and better biomarkers and predictors of outcome. All patients seen in any of the Hepatology Clinics who are potential candidates for new therapies and other research protocols are referred for participation in clinical stuides.

Our faculty play key roles in multiple clinical research networks sponsored by the National Institutes of Health (NIH) including acute liver failure, biomarkers for early diagnosis of hepatocellular carcinoma, drug-induced liver injury, hepatitis B and hepatitis C.

The program is also involved in many clinical studies supported by pharmaceutical companies that evaluate new therapies for various liver diseases including hepatitis B and C, fatty liver disease, and hepatocellular carcinoma.